Although our results revealed that the enzyme activity of KDM5C was not required for this regulation, epigenetic modifiers, such as the DNA methyltransferase DNMT3A [34] and histone methyltransferase EZH2 [35, 36], could regulate the disease stages of AML. Here, PRDM9 is linked to acute myeloid leukemia.